Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-05

FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Chlorpromazine Hydrochloride from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHLORPROMAZINE HYDROCHLORIDE (Chlorpromazine hydrochloride)

Snippet

SUPPL AP for CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)